Healthcare provider profile · identity verified

Karen Magit

Nurse Practitioner · NATICK, MA · NPI 1083223630

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	455	72
Levothyroxine Sodium	Levothyroxine Sodium	408	51
Furosemide	Furosemide	266	44
Amlodipine Besylate	Amlodipine Besylate	259	39
Eliquis	Apixaban	204	31
Mirtazapine	Mirtazapine	204	31
Trazodone Hcl	Trazodone Hcl	204	37
Omeprazole	Omeprazole	198	27
Metoprolol Succinate	Metoprolol Succinate	196	31
Quetiapine Fumarate	Quetiapine Fumarate	175	23
Gabapentin	Gabapentin	167	33
Lisinopril	Lisinopril	165	34
Divalproex Sodium	Divalproex Sodium	152	23
Losartan Potassium	Losartan Potassium	149	22
Donepezil Hcl	Donepezil Hcl	145	25
Metformin Hcl	Metformin Hcl	145	21
Metoprolol Tartrate	Metoprolol Tartrate	130	22
Sertraline Hcl	Sertraline Hcl	125	21
Escitalopram Oxalate	Escitalopram Oxalate	123	22
Pantoprazole Sodium	Pantoprazole Sodium	113	20
Simvastatin	Simvastatin	101	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	92	50
Tamsulosin Hcl	Tamsulosin Hcl	89	17
Potassium Chloride	Potassium Chloride	88	13
Hydrochlorothiazide	Hydrochlorothiazide	87	16
Oxybutynin Chloride Er	Oxybutynin Chloride	82	suppressed
Memantine Hcl	Memantine Hcl	81	11
Olanzapine	Olanzapine	80	14
Citalopram Hbr	Citalopram Hydrobromide	76	11
Famotidine	Famotidine	72	12
Duloxetine Hcl	Duloxetine Hcl	61	13
Lorazepam	Lorazepam	59	suppressed
Pravastatin Sodium	Pravastatin Sodium	56	suppressed
Spironolactone	Spironolactone	55	suppressed
Torsemide	Torsemide	55	suppressed
Levetiracetam	Levetiracetam	54	suppressed
Tramadol Hcl	Tramadol Hcl	53	suppressed
Clonazepam	Clonazepam	52	suppressed
Buspirone Hcl	Buspirone Hcl	50	suppressed
Ezetimibe	Ezetimibe	48	suppressed
Nystatin	Nystatin	47	18
Carbidopa-Levodopa	Carbidopa/Levodopa	44	suppressed
Jardiance	Empagliflozin	44	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	44	suppressed
Glipizide	Glipizide	43	suppressed
Bupropion Xl	Bupropion Hcl	41	suppressed
Methenamine Hippurate	Methenamine Hippurate	41	suppressed
Baclofen	Baclofen	40	suppressed
Finasteride	Finasteride	40	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	38	18
Bupropion Hcl Sr	Bupropion Hcl	37	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	36	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	35	suppressed
Risperidone	Risperidone	35	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	35	suppressed
Atenolol	Atenolol	34	suppressed
Latanoprost	Latanoprost	33	suppressed
Midodrine Hcl	Midodrine Hcl	33	suppressed
Xarelto	Rivaroxaban	32	suppressed
Januvia	Sitagliptin Phosphate	31	suppressed
Sucralfate	Sucralfate	31	suppressed
Oxcarbazepine	Oxcarbazepine	30	suppressed
Alendronate Sodium	Alendronate Sodium	29	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	29	suppressed
Levofloxacin	Levofloxacin	29	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Montelukast Sodium	Montelukast Sodium	27	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	27	suppressed
Clopidogrel	Clopidogrel Bisulfate	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Glimepiride	Glimepiride	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Memantine Hcl Er	Memantine Hcl	26	suppressed
Cephalexin	Cephalexin	25	17
Digoxin	Digoxin	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Konvomep	Omeprazole/Sodium Bicarbonate	24	suppressed
Doxepin Hcl	Doxepin Hcl	22	suppressed
Lamotrigine	Lamotrigine	22	suppressed
Myrbetriq	Mirabegron	22	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	17
Carvedilol	Carvedilol	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	17
Glipizide Er	Glipizide	19	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	15
Fluticasone Propionate	Fluticasone Propionate	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Valsartan	Valsartan	17	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	16	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Haloperidol	Haloperidol	16	suppressed
Allopurinol	Allopurinol	15	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Prednisone	Prednisone	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Alprazolam	Alprazolam	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Nystop	Nystatin	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Timolol Maleate	Timolol Maleate	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	13	12
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Guanfacine Hcl Er	Guanfacine Hcl	13	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	13	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	13	suppressed
Perphenazine	Perphenazine	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Azithromycin	Azithromycin	12	11
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Exemestane	Exemestane	12	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	12	suppressed
Megestrol Acetate	Megestrol Acetate	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Rivastigmine	Rivastigmine Tartrate	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Bicalutamide	Bicalutamide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error